Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
| SMGIX Fund | USD 39.44 0.22 0.56% |
Slightly above 52% of Columbia Contrarian's investor base is interested to short. The analysis of overall sentiment of trading Columbia Trarian Core mutual fund suggests that many investors are impartial at this time. Columbia Contrarian's investing sentiment can be driven by a variety of factors including economic data, Columbia Contrarian's earnings reports, geopolitical events, and overall market trends.
Columbia |
Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 IND enabling studies underway, with Phase I initiation expected in Q425Webcast and conference call to be held today at 430 pm ET
Read at newswire.com
 |
Columbia Contrarian Fundamental Analysis
We analyze Columbia Contrarian's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Columbia Contrarian using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Columbia Contrarian based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Columbia Trarian is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Columbia Trarian Core Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Columbia Contrarian mutual fund to make a market-neutral strategy. Peer analysis of Columbia Contrarian could also be used in its relative valuation, which is a method of valuing Columbia Contrarian by comparing valuation metrics with similar companies.
Peers
Columbia Contrarian Related Equities
| GEGTX | Columbia Large | 1.07 | ||||
| WCEYX | Ivy Core | 0.57 | ||||
| GSFTX | Columbia Dividend | 0.30 | ||||
| CBALX | Columbia Balanced | 0.25 | ||||
| JGMRX | Janus Triton | 0.26 |
Other Information on Investing in Columbia Mutual Fund
Columbia Contrarian financial ratios help investors to determine whether Columbia Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Columbia with respect to the benefits of owning Columbia Contrarian security.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |